Wet Age-Related Macular Degeneration: Trends in Real-World Treatment Patterns in the United States
An OMNY Health™ Poster
Our objective was to characterize real-world treatment patterns among wet AMD patients in diverse healthcare delivery settings in the United States (US)
On November 6-9, 2022, this poster was on display at ISPOR Europe
Discussion and Conclusions:
-
Results provide insights into real-world treatment patterns for wet AMD within a diverse set of US healthcare settings
-
Bevacizumab has seen a big increase in usage in the last couple of years and was the most utilized treatment observed
-
As new treatments are developed and introduced, future analyses would be helpful to understand uptake of thearpies and prescription patterns among wet AMD patients